BIOMAT Database Logo BIOMAT Database Logo

FoxP3+ regulatory T cells are distinct from leukemia cells in HTLV-1-associated adult T-cell leukemia. 2009

Frederic Toulza, and Kisato Nosaka, and Masafumi Takiguchi, and Tony Pagliuca, and Hiroaki Mitsuya, and Yuetsu Tanaka, and Graham P Taylor, and Charles R M Bangham
Department of Immunology, Imperial College, London, United Kingdom. f.toulza@imperial.ac.uk

Human T-lymphotropic virus type 1 (HTLV-1) is the causative agent of adult T-cell leukemia/lymphoma (ATLL). It has been postulated that ATLL cells might act as regulatory T cells (T(regs)) which, in common with ATLL cells, express both CD25 and FoxP3, and so contribute to the severe immune suppression typical of ATLL. We report here that the frequency of CD25(+) cells varied independently of the frequency of FoxP3(+) cells in both a cross-sectional study and in a longitudinal study of 2 patients with chronic ATLL. Furthermore, the capacity of ATLL cells to suppress proliferation of heterologous CD4(+)CD25(-) cells correlated with the frequency of CD4(+) FoxP3(+) cells but was independent of CD25 expression. Finally, the frequency of CD4(+)FoxP3(+) cells was inversely correlated with the lytic activity of HTLV-1-specific CTLs in patients with ATLL. We conclude that ATLL is not a tumor of FoxP3(+) regulatory T cells, and that a population of FoxP3(+) cells distinct from ATLL cells has regulatory functions and may impair the cell-mediated immune response to HTLV-1 in patients with ATLL.

UI MeSH Term Description Entries
D008137 Longitudinal Studies Studies in which variables relating to an individual or group of individuals are assessed over a period of time. Bogalusa Heart Study,California Teachers Study,Framingham Heart Study,Jackson Heart Study,Longitudinal Survey,Tuskegee Syphilis Study,Bogalusa Heart Studies,California Teachers Studies,Framingham Heart Studies,Heart Studies, Bogalusa,Heart Studies, Framingham,Heart Studies, Jackson,Heart Study, Bogalusa,Heart Study, Framingham,Heart Study, Jackson,Jackson Heart Studies,Longitudinal Study,Longitudinal Surveys,Studies, Bogalusa Heart,Studies, California Teachers,Studies, Jackson Heart,Studies, Longitudinal,Study, Bogalusa Heart,Study, California Teachers,Study, Longitudinal,Survey, Longitudinal,Surveys, Longitudinal,Syphilis Studies, Tuskegee,Syphilis Study, Tuskegee,Teachers Studies, California,Teachers Study, California,Tuskegee Syphilis Studies
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D005260 Female Females
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D015368 Human T-lymphotropic virus 1 A strain of PRIMATE T-LYMPHOTROPIC VIRUS 1 isolated from mature T4 cells in patients with T-lymphoproliferation malignancies. It causes adult T-cell leukemia (LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED), T-cell lymphoma (LYMPHOMA, T-CELL), and is involved in mycosis fungoides, SEZARY SYNDROME and tropical spastic paraparesis (PARAPARESIS, TROPICAL SPASTIC). ATLV,Adult T-Cell Leukemia-Lymphoma Virus I,HTLV-1,HTLV-I,Human T-Cell Leukemia Virus I,Leukemia Virus I, Human T-Cell,T-Cell Leukemia Virus I, Human,Adult T Cell Leukemia Lymphoma Virus I,Human T Cell Leukemia Virus I,Leukemia Lymphoma Virus I, Adult T Cell,Leukemia Virus I, Human T Cell,T Cell Leukemia Virus I, Human,Human T lymphotropic virus 1

Related Publications

Frederic Toulza, and Kisato Nosaka, and Masafumi Takiguchi, and Tony Pagliuca, and Hiroaki Mitsuya, and Yuetsu Tanaka, and Graham P Taylor, and Charles R M Bangham
Regulatory T cell-like activity of Foxp3+ adult T cell leukemia cells.
February 2006, International immunology,
Frederic Toulza, and Kisato Nosaka, and Masafumi Takiguchi, and Tony Pagliuca, and Hiroaki Mitsuya, and Yuetsu Tanaka, and Graham P Taylor, and Charles R M Bangham
Adult T cell leukemia/lymphoma: FoxP3(+) cells and the cell-mediated immune response to HTLV-1.
January 2011, Advances in cancer research,
Frederic Toulza, and Kisato Nosaka, and Masafumi Takiguchi, and Tony Pagliuca, and Hiroaki Mitsuya, and Yuetsu Tanaka, and Graham P Taylor, and Charles R M Bangham
HTLV-1 and associated adult T-cell leukemia/lymphoma.
December 2003, Reviews in clinical and experimental hematology,
Frederic Toulza, and Kisato Nosaka, and Masafumi Takiguchi, and Tony Pagliuca, and Hiroaki Mitsuya, and Yuetsu Tanaka, and Graham P Taylor, and Charles R M Bangham
HTLV-1-associated adult T-cell leukemia/lymphoma with disseminated strongyloidiasis.
June 2019, Blood,
Frederic Toulza, and Kisato Nosaka, and Masafumi Takiguchi, and Tony Pagliuca, and Hiroaki Mitsuya, and Yuetsu Tanaka, and Graham P Taylor, and Charles R M Bangham
HTLV-1 Tax and adult T-cell leukemia.
January 2007, Frontiers in bioscience : a journal and virtual library,
Frederic Toulza, and Kisato Nosaka, and Masafumi Takiguchi, and Tony Pagliuca, and Hiroaki Mitsuya, and Yuetsu Tanaka, and Graham P Taylor, and Charles R M Bangham
Adult T-cell leukemia/lymphoma and HTLV-1.
October 2007, Current hematologic malignancy reports,
Frederic Toulza, and Kisato Nosaka, and Masafumi Takiguchi, and Tony Pagliuca, and Hiroaki Mitsuya, and Yuetsu Tanaka, and Graham P Taylor, and Charles R M Bangham
[Adult T-cell leukemia, HTLV-I associated bronchopneumonopathy].
January 1994, Ryoikibetsu shokogun shirizu,
Frederic Toulza, and Kisato Nosaka, and Masafumi Takiguchi, and Tony Pagliuca, and Hiroaki Mitsuya, and Yuetsu Tanaka, and Graham P Taylor, and Charles R M Bangham
Distinct IkappaB kinase regulation in adult T cell leukemia and HTLV-I-transformed cells.
August 2005, Experimental cell research,
Frederic Toulza, and Kisato Nosaka, and Masafumi Takiguchi, and Tony Pagliuca, and Hiroaki Mitsuya, and Yuetsu Tanaka, and Graham P Taylor, and Charles R M Bangham
Human T-lymphotropic virus 1 (HTLV-1)-associated lichenoid dermatitis induced by CD8+ T cells in HTLV-1 carrier, HTLV-1-associated myelopathy/tropical spastic paraparesis and adult T-cell leukemia/lymphoma.
October 2015, The Journal of dermatology,
Frederic Toulza, and Kisato Nosaka, and Masafumi Takiguchi, and Tony Pagliuca, and Hiroaki Mitsuya, and Yuetsu Tanaka, and Graham P Taylor, and Charles R M Bangham
HTLV-1 associated myelopathy/tropical spastic paraparesis with adult T-cell leukemia.
January 1992, Leukemia,
Copied contents to your clipboard!